森下仁丹の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/06/24 | 2,191 | 2,191 | 2,174 | 2,187 | +5 | +0.2% | 1,000 |
| 2024/06/21 | 2,182 | 2,185 | 2,182 | 2,182 | +1 | ±0% | 1,000 |
| 2024/06/20 | 2,180 | 2,181 | 2,180 | 2,181 | +2 | +0.1% | 900 |
| 2024/06/19 | 2,168 | 2,179 | 2,167 | 2,179 | +10 | +0.5% | 600 |
| 2024/06/18 | 2,165 | 2,169 | 2,157 | 2,169 | +9 | +0.4% | 1,300 |
| 2024/06/17 | 2,165 | 2,170 | 2,160 | 2,160 | -6 | -0.3% | 2,800 |
| 2024/06/14 | 2,180 | 2,180 | 2,162 | 2,166 | -6 | -0.3% | 1,500 |
| 2024/06/13 | 2,170 | 2,173 | 2,170 | 2,172 | +3 | +0.1% | 500 |
| 2024/06/12 | 2,189 | 2,189 | 2,169 | 2,169 | -16 | -0.7% | 1,500 |
| 2024/06/11 | 2,177 | 2,191 | 2,177 | 2,185 | +12 | +0.6% | 700 |
| 2024/06/10 | 2,184 | 2,189 | 2,173 | 2,173 | -14 | -0.6% | 2,900 |
| 2024/06/07 | 2,188 | 2,188 | 2,186 | 2,187 | -1 | ±0% | 300 |
| 2024/06/06 | 2,196 | 2,196 | 2,188 | 2,188 | -14 | -0.6% | 1,300 |
| 2024/06/05 | 2,207 | 2,207 | 2,201 | 2,202 | -5 | -0.2% | 800 |
| 2024/06/04 | 2,200 | 2,211 | 2,200 | 2,207 | +7 | +0.3% | 500 |
| 2024/06/03 | 2,196 | 2,217 | 2,196 | 2,200 | +4 | +0.2% | 1,600 |
| 2024/05/31 | 2,161 | 2,200 | 2,161 | 2,196 | +35 | +1.6% | 1,700 |
| 2024/05/30 | 2,209 | 2,209 | 2,161 | 2,161 | -34 | -1.5% | 5,000 |
| 2024/05/29 | 2,192 | 2,204 | 2,190 | 2,195 | -1 | ±0% | 2,000 |
| 2024/05/28 | 2,213 | 2,213 | 2,195 | 2,196 | -14 | -0.6% | 1,100 |
| 2024/05/27 | 2,198 | 2,215 | 2,191 | 2,210 | +20 | +0.9% | 2,100 |
| 2024/05/24 | 2,180 | 2,193 | 2,180 | 2,190 | +8 | +0.4% | 1,300 |
| 2024/05/23 | 2,189 | 2,190 | 2,180 | 2,182 | -7 | -0.3% | 3,500 |
| 2024/05/22 | 2,204 | 2,204 | 2,189 | 2,189 | -7 | -0.3% | 1,800 |
| 2024/05/21 | 2,194 | 2,205 | 2,194 | 2,196 | +2 | +0.1% | 600 |
| 2024/05/20 | 2,200 | 2,210 | 2,191 | 2,194 | -5 | -0.2% | 3,900 |
| 2024/05/17 | 2,176 | 2,211 | 2,176 | 2,199 | +11 | +0.5% | 2,200 |
| 2024/05/16 | 2,210 | 2,210 | 2,175 | 2,188 | -23 | -1% | 7,600 |
| 2024/05/15 | 2,229 | 2,229 | 2,211 | 2,211 | -24 | -1.1% | 2,300 |
| 2024/05/14 | 2,222 | 2,235 | 2,210 | 2,235 | +20 | +0.9% | 7,300 |
| 2024/05/13 | 2,246 | 2,246 | 2,210 | 2,215 | -31 | -1.4% | 14,800 |
| 2024/05/10 | 2,264 | 2,319 | 2,220 | 2,246 | -236 | -9.5% | 68,700 |
| 2024/05/09 | 2,435 | 2,520 | 2,411 | 2,482 | +47 | +1.9% | 17,700 |
| 2024/05/08 | 2,416 | 2,443 | 2,416 | 2,435 | +14 | +0.6% | 1,100 |
| 2024/05/07 | 2,445 | 2,447 | 2,404 | 2,421 | -6 | -0.2% | 800 |
| 2024/05/02 | 2,428 | 2,429 | 2,403 | 2,427 | +20 | +0.8% | 800 |
| 2024/05/01 | 2,400 | 2,407 | 2,400 | 2,407 | +23 | +1% | 500 |
| 2024/04/30 | 2,383 | 2,400 | 2,382 | 2,384 | -1 | ±0% | 1,100 |
| 2024/04/26 | 2,393 | 2,410 | 2,385 | 2,385 | -31 | -1.3% | 1,400 |
| 2024/04/25 | 2,441 | 2,441 | 2,366 | 2,416 | -25 | -1% | 800 |
| 2024/04/24 | 2,437 | 2,445 | 2,411 | 2,441 | +4 | +0.2% | 1,600 |
| 2024/04/23 | 2,361 | 2,468 | 2,361 | 2,437 | +114 | +4.9% | 7,100 |
| 2024/04/22 | 2,308 | 2,350 | 2,308 | 2,323 | +17 | +0.7% | 1,400 |
| 2024/04/19 | 2,351 | 2,351 | 2,300 | 2,306 | -45 | -1.9% | 8,800 |
| 2024/04/18 | 2,360 | 2,377 | 2,340 | 2,351 | -35 | -1.5% | 2,400 |
| 2024/04/17 | 2,385 | 2,432 | 2,363 | 2,386 | -49 | -2% | 2,300 |
| 2024/04/16 | 2,429 | 2,469 | 2,350 | 2,435 | +7 | +0.3% | 4,000 |
| 2024/04/15 | 2,482 | 2,482 | 2,424 | 2,428 | -28 | -1.1% | 3,100 |
| 2024/04/12 | 2,405 | 2,467 | 2,405 | 2,456 | +51 | +2.1% | 1,500 |
| 2024/04/11 | 2,439 | 2,439 | 2,405 | 2,405 | -33 | -1.4% | 400 |
201～
250
件表示中 / 3683件
類似銘柄と比較する
現在ご覧いただいている「仁 丹」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 仁 丹 | 208,500円 | +2.4% | +10.4% | 2.64% | 12.19倍 | 0.68倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
| ＮＡＮＯ | 13,500円 | -20.0% | - | 0.00% | - | 3.13倍 |
|
ｍＲＮＡ医薬品に特化した創薬ベンチャー。創薬シーズ発掘から非臨床開発まで手がけて導出 |
| カイオム | 13,500円 | +92.3% | - | 0.00% | - | 4.79倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
| サイフューズ | 103,900円 | +459.3% | - | 0.00% | - | 3.41倍 |
|
バイオ３Ｄプリンタを開発、自家細胞製品の製造受託も。臓器など再生医療等製品を臨床開発中 |
| ラクオリア | 35,700円 | +25.1% | - | 0.00% | - | 1.41倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
市場注目の銘柄
チャート関連のコラム
